Physician profile
Jennifer Abelson
NPI 1326505330
$1,075.26
in general payments reported to CMS, 2019-2025
20 companies · $22.72 in 2025
The $22.72 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $89.39 · 2023: $531 · 2024: $40.18 · 2025: $22.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $189.58 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $184.26 | 2021-2023 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.62 | 2021-2024 | Relistor |
| Lundbeck LLC | $143.82 | 2022-2023 | Vyepti |
| Biodelivery Sciences International, INC. | $53.56 | 2021 | |
| Alkermes, INC. | $47.09 | 2021 | |
| Nevro Corp. | $39.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $39.36 | 2021 | |
| Abbvie INC. | $33.76 | 2023 | Ubrelvy, Qulipta |
| Arbor Pharmaceuticals, INC. | $24.63 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.51 | 2021 | |
| Scilex Pharmaceuticals INC. | $22.30 | 2023 | Ztlido |
| Si-Bone, INC. | $21.50 | 2024 | |
| Amneal Pharmaceuticals LLC | $18.58 | 2023 | Lyvispah |
| Almatica Pharma LLC | $15.18 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $15.12 | 2021 | |
| Pacira Therapeutics, INC. | $14.18 | 2021 | |
| Pfizer INC. | $13.22 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.76 | 2023 | Exparel, Iovera, Zilretta |
| Amgen INC. | $12.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Abelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.